Biotech stocks have been on fire for the past year. When the time into 2021, investor enthusiasm aren't still reducing for the biotech field. Many biotech stocks have created a high returns for investors, such as Novavax, Vaxart and Moderna.

Unlike other sectors, Companies in the industry typically reinvest more than 20% of their revenue in developing new treatment and therapies, that is one major driver behind biotech firms' momentum. For now, some clinical trial and new technologies developing are still in progress in companies with huge potential. So, today,  let's take eyes on top 3 biotech penny stocks and could they add wealth to your portfolio?

3 Best Penny Stocks to Watch in March 2021

CompanyPrice ($)Market-cap (M)
Fortress Biotech Inc (FBIO)
4.60
431.03
Assertio Therapeutics Inc (ASRT)
1.12
184.55
Transenterix Inc (TRXC)
4.52
629.70

(source:investing.com)

Fortress Biotech

Fortress Biotech operates a diversified business. It targets a broad range of treatment areas, all of which have bright growth potential because of unmet demand. Additionally, the company operates through multiple subsidiaries, many of which have entered very valuable partnerships.

Assertio Therapeutics 

Assertio is a leading commercial pharmaceutical company bringing differentiated products to patients. The Company has a robust portfolio of branded prescription products in three areas: neurology, hospital, and pain and inflammation.

Transenterix

TransEnterix is a medical device company. The Company is engaged in digitizing the interface between the surgeon and the patient to improve minimally invasive surgery (MIS) through digital laparoscopy. The Senhance system is a machine vision system for use in robotic surgery, which is powered by intelligent surgical unit that enables augmented intelligence in surgery. 

Disclaimer: The opinions expressed in this article are solely those of the featured analysts. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.